Carregant...
Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review
CONTEXT: Most recently developed anti-hyperglycemic drugs have offered cardiovascular and renal benefits. In this narrative review, we discuss the cardiovascular and renal benefits of novel antidiabetic drugs, sodium glucose cotransporter type 2 (SGLT2) inhibitors, in type 2 diabetes. EVIDENCE ACQUI...
Guardat en:
| Publicat a: | Int J Endocrinol Metab |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Kowsar
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6628616/ https://ncbi.nlm.nih.gov/pubmed/31372172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/ijem.84353 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|